Quest Ventures, a Singapore-headquartered venture capital firm, has achieved the first close for a new fund. The target for the vehicle is $50 million.
QazTech Ventures, a subsidiary of Kazakhstani sovereign fund Baiterek National Management, has contributed $10 million to Quest Ventures' second fund, according to an announcement on Strategy 2050, a state-run...
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.
Biocytogen, a Chinese contract research organization (CRO) that provides genetically-modified mice for drug testing, has raised RMB970 million ($143 million) in an extended tranche of Series D funding.